Alyeska reports 8.69% stake in RH
Alyeska Investment Group reports beneficial ownership of 1,636,323 shares of RH common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alyeska Investment Group reports beneficial ownership of 1,636,323 shares of RH common stock. The filing states this represents 8.69% of the class. The filing cites shares outstanding were 18,834,576 as of March 31, 2026 per the Form 10-K dated April 1, 2026. The statement is a joint Schedule 13G filed by Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh, with shared voting and dispositive power over the disclosed shares.
Insights
Large passive stake disclosed; governance influence depends on holder intent.
The Schedule 13G shows Alyeska-related entities beneficially own 1,636,323 shares (8.69%). As a 13G, it typically signals a passive investor position rather than an activist intent. The filing records shared voting and dispositive power over these shares.
Maintain attention to future amendments or a conversion to a Schedule 13D, which would indicate active acquisition plans; subsequent filings will clarify any change in intent.
Key Figures
Key Terms
Schedule 13G regulatory
beneficially own financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Alyeska report in RH (symbol: RH)?
Does the Schedule 13G indicate Alyeska is an active or passive investor in RH?
AI-generated analysis. How Rhea-AI works. Not financial advice.